Walleye Trading LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,215,647
+49.5%
109,022
+41.2%
0.03%
+30.8%
Q2 2023$8,840,944
-74.1%
77,200
-68.8%
0.03%
-64.9%
Q1 2023$34,150,001
+89.9%
247,769
+78.5%
0.07%
+42.3%
Q4 2022$17,985,704
-6.5%
138,800
-20.3%
0.05%
-11.9%
Q3 2022$19,245,000
+1377.0%
174,100
+1103.3%
0.06%
+1375.0%
Q4 2021$1,303,000
-28.1%
14,468
-26.2%
0.00%
-42.9%
Q3 2021$1,813,000
-49.8%
19,600
-57.8%
0.01%
-50.0%
Q2 2021$3,609,000
+95.0%
46,427
+87.0%
0.01%
+75.0%
Q1 2021$1,851,000
+101.0%
24,826
+359.7%
0.01%
+100.0%
Q4 2020$921,000
-63.4%
5,400
-69.8%
0.00%
-71.4%
Q3 2020$2,514,000
-3.8%
17,900
+9.8%
0.01%
-17.6%
Q2 2020$2,614,000
-49.8%
16,300
-69.4%
0.02%
-57.5%
Q1 2020$5,205,000
-62.7%
53,221
-50.8%
0.04%
-58.8%
Q4 2019$13,949,000
+2619.1%
108,100
+1489.7%
0.10%
+2325.0%
Q3 2019$513,000
-79.9%
6,800
-59.5%
0.00%
-81.8%
Q2 2019$2,553,000
+289.8%
16,800
+205.5%
0.02%
+340.0%
Q1 2019$655,000
-15.3%
5,499
-22.4%
0.01%0.0%
Q4 2018$773,000
-30.1%
7,088
+3.6%
0.01%
-16.7%
Q3 2018$1,106,000
-7.7%
6,845
-24.4%
0.01%
-14.3%
Q2 2018$1,198,000
+387.0%
9,060
+126.5%
0.01%
+250.0%
Q3 2016$246,000
+459.1%
4,000
+73.9%
0.00%
Q2 2016$44,0002,3000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders